Q2 2020
Released Aug 11, 2020, before the open
10-Q filed Aug 11, 2020, 42 days after period end · 0001493152-20-015271
Q2 2020 · 10-Q
Revenue$3.62M$3.62M +119.4% vs Q2 2019+91.9% vs Q1 2020
Net Income$70.00K$70.00K N/M vs Q2 2019N/M vs Q1 2020
EPS Diluted$0.01$0.01 N/M vs Q2 2019N/M vs Q1 2020
Gross Profit$1,279,000+390.0%
Operating Income$59,000N/M
Operating Cash Flowderived$4,372,000N/M
Free Cash Flowderived$4,341,000N/M
Margins · derived
Gross margin35.3%+19.5 pt vs Q2 2019
Operating margin1.6%+78.4 pt vs Q2 2019
Net margin1.9%+76.9 pt vs Q2 2019
What the release said
The release
Same quarter
| Metric | Q2 2020 | Q2 2019 | Q2 2018 | Q2 2017 |
|---|---|---|---|---|
| Revenue | $3.62M | $1.65M | $3.19M | $1.91M |
| Net Income | $70.00K | -$1.24M | -$259.00K | -$2.31M |
| EPS Diluted | $0.01 | -$0.11 | -$0.02 | -$0.14 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
ProPhase Labs, Inc. · CIK 868278 · Engraved from SEC EDGAR